Physiomics vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.
Registrars:
Key Personnel
CEO:
Peter Sargent
Non-Executive Chairman:
James Simon Millen
Independent Non-Executive Director:
Timothy (Tim) Corn, Shalabh Kumar
Contact Details
Address:
Bee House, 140 Eastern Avenue, Milton Park, Oxfordshire, United Kingdom